Clean Yield Group’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-39
Closed -$14.4K 463
2024
Q4
$14.4K Sell
39
-2
-5% -$837 ﹤0.01% 308
2024
Q3
$21.3K Buy
41
+2
+5% +$1.07K 0.01% 291
2024
Q2
$21.1K Hold
39
0.01% 281
2024
Q1
$20.2K Hold
39
0.01% 287
2023
Q4
$18.4K Hold
39
0.01% 286
2023
Q3
$17.7K Hold
39
0.01% 290
2023
Q2
$17.3K Hold
39
0.01% 300
2023
Q1
$17.9K Sell
39
-30
-43% -$14.3K 0.01% 292
2022
Q4
$35.4K Hold
69
0.02% 257
2022
Q3
$31K Hold
69
0.01% 257
2022
Q2
$33K Hold
69
0.01% 265
2022
Q1
$34K Buy
+69
New +$31.5K 0.01% 276
2021
Q1
Sell
-111
Closed -$36K 214
2020
Q4
$36K Hold
111
0.01% 270
2020
Q3
$30K Hold
111
0.01% 248
2020
Q2
$29K Hold
111
0.01% 241
2020
Q1
$25K Hold
111
0.01% 254
2019
Q4
$34K Sell
111
-16
-13% -$4.4K 0.01% 250
2019
Q3
$30K Hold
127
0.01% 246
2019
Q2
$36K Buy
+127
New +$34.7K 0.01% 226

Other funds holding ELV

Clean Yield Group's ELV Position: Q1 2025 in Review

Clean Yield Group sold out of Elevance Health (ELV) in Q1 2025, closing a stake of 39 shares — an estimated $14.4K sold.

Clean Yield Group first reported a position in ELV in Q2 2019 and held it in 19 quarters. The position peaked at $36K in Q4 2020. 1,660 funds tracked by Wall St. Rank hold ELV as of Q1 2025.

  • Clean Yield Group reported no remaining Elevance Health position as of Q1 2025 after selling out during the quarter.
  • Clean Yield Group sold 39 Elevance Health shares in Q1 2025, an estimated $14.4K.
  • Clean Yield Group first reported a position in Elevance Health in Q2 2019 and held it in 19 quarters.
  • Clean Yield Group's Elevance Health position peaked at $36K in Q4 2020.
  • 1,660 funds tracked by Wall St. Rank held Elevance Health as of Q1 2025.

Based on Clean Yield Group's 13F filing for Q1 2025, filed 14 Apr 2025.